Correlation of the clinical history and pathology established a diagnosis of metastatic papillary thyroid carcinoma to skin. The residual tumor on the nose was excised without recurrence. However, within 6 months, he had progressive shortness of breath; follow up studies showed progressive chest disease.
His tumor was sent for genomic studies (Foundation One, Cambridge, MA). An aberration in the rearranged during transfection (RET) receptor tyrosine kinase was identified: an in-frame fusion of coiled-coil domain containing 6 (CCDC6) up to intron 1, with RET from intron 11 to the end. Treatment was initiated and maintained with the RET inhibitor vandetanib; he has had stable metastatic disease without symptoms 1.5 years after starting this drug.
Discussion
Cutaneous metastases may develop in patients with an established diagnosis of cancer. In this setting, they typically herald the onset of either relapsing or progressive disease in an oncology patient. However-albeit less commonly-they can be the initial presentation of an unsuspected internal malignancy in a previously cancer-free individual. However, albeit rare, papillary and follicular thyroid carcinoma have both been associated with skin metastases [1, 2] .
Cutaneous metastases from papillary thyroid carcinoma are reported in less than 1 in 1,000 patients with this cancer [2] . The scalp is the most frequent site [3] [4] [5] [6] [7] . A man with progressing metastatic papillary thyroid cancer to lung who developed a cutaneous metastasis on the nose mimicking a basal cell carcinoma is described and the various clinical presentations of metastatic papillary thyroid cancer to skin are reviewed.
Case report
A 72-year-old man was referred by his oncologist for evaluation of a lesion on his nose that was suspected to be a basal cell carcinoma. The lesion was painless and had appeared 3 weeks earlier. A B
(a type II keratin found in the follicular cells of the thyroid gland) [11] and paired box gene 8 (PAX8, a nephric-lineage transcription factor that is a crucial transcription factor for the organogenesis of the kidney, the Mullerian system and the thyroid gland) [12] .
The nose is an unusual site for cutaneous metastases. In addition to thyroid carcinoma, other cancers with metastatic lesions on the nose include solid tumors originating from the breast, cervix, liver, lung and testes [13] ; immunohistochemical markers can be used to differentiate the organ of origin of these metastatic tumors ( Table 1 ). The described patient was referred for evaluation of a suspected basal cell carcinoma.
Morphologic features of the nodule that suggested the possibility of metastatic tumor included its violaceous appearance and the absence of telangiectasias.
In addition to the patient in this report, another man with papillary thyroid carcinoma also had a cutaneous metastasis on his nose; in this individual, the nose lesion was the initial presentation of his metastatic disease [14] . He was a 73-yearold Caucasian man who developed a raised, non-pigmented lesion on his left nasal ridge; biopsy revealed papillary thyroid carcinoma. In addition to a thyroid mass, he had metastases to his lungs, bone and liver. Management included a partial thyroidectomy, palliative radiotherapy (to the neck and cervical spine to treat tracheal invasion of the tumor and spinal cord compression, respectively), doxorubicin and radioactive
The morphology of cutaneous metastases is variable. The lesions can present as patches, plaques, papules or nodules.
They can mimic other conditions such as alopecia, infections (erysipelas and paronychia), benign cysts (epidermoid or pilar), pyogenic granuloma and cutaneous malignant neoplasms (basal cell carcinoma and keratoacanthoma) [4, 5, 7] .
Common skin manifestations of metastatic papillary thyroid cancer, in addition to scalp nodules, include neck nodules [3, 4, 8] and lesions on the thyroidectomy scar [1] .
Metastatic tumor at the fine-needle aspiration biopsy site has been observed [8] . Also, lesions of cutaneous papillary thyroid carcinoma metastases have been described on the abdominal wall [6, 9] , arm [6] , buttock [9] , chest wall [3] , face [3, 6] , shoulder [6] and thigh [9] . The prognosis for patients with metastatic papillary thyroid carcinoma to the skin, in general, is unfavorable [3, 5] . However, there are several individuals with metastatic papillary thyroid carcinoma who survive several years after diagnosis with indolent disease [1, 3, 9] . Also, similar to the described patient, with the advent of molecular targeted therapies, such as tyrosine kinase inhibitors, the prognosis for patients with metastatic disease-and particularly those with rearranged during transfection (RET) proto-oncogene aberrations-is better than that observed in individuals with papillary thyroid carcinoma who were treated prior to the discovery of these agents [15] .
Conclusion
Papillary thyroid carcinoma with skin metastases is rare.
Cutaneous metastases of papillary thyroid carcinoma most commonly occur as nodules on the scalp, neck, and thyroidectomy scars. A man with progressive metastatic papillary thyroid carcinoma developed a cutaneous metastasis on his nose; the lesion morphologically mimicked a basal cell carcinoma. Cutaneous papillary thyroid carcinoma metastases
